Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
8.36%Depreciation and Amortization Margin
VS
Market
Sector
Industry
History
$ 7.8Close
$ 3.84 - $ 23.39 52-Week Range
Ticker Information
Ticker
MYGNCompany Name
MYRIAD GENETICS INCSector
HealthcareIndustry
Diagnostics & ResearchExchange
NASDAQMYRIAD GENETICS INC - Depreciation and Amortization Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
MYGN - DepAmor % Historical data
| Date | Depreciation, Amortization & Accretion | Depreciation and Amortization Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 69.6M | 8.36% | $ 832.9M |
| 3/31/2025 | $ 69.9M | 8.41% | $ 831.3M |
| 12/31/2024 | $ 70.7M | 8.44% | $ 837.6M |
| 9/30/2024 | $ 70.9M | 8.61% | $ 823.6M |
| 6/30/2024 | $ 69.9M | 8.71% | $ 802.2M |
| 3/31/2024 | $ 68.9M | 8.9% | $ 774.2M |
| 12/31/2023 | $ 73.2M | 9.72% | $ 753.2M |
| 9/30/2023 | $ 72.2M | 9.83% | $ 734.4M |
| 6/30/2023 | $ 71.3M | 10.2% | $ 698.9M |
| 3/31/2023 | $ 70.6M | 10.16% | $ 694.7M |
Key Performance Insights, Last 5 Years
- MYRIAD GENETICS INC's latest trailing twelve months (TTM) DepAmor % stands at 12.52%.
- Over the past 5 years, MYRIAD GENETICS INC's average DepAmor % has been 10.34%.
- The median DepAmor % for MYRIAD GENETICS INC during this period was 9.77%
- MYRIAD GENETICS INC reached its highest DepAmor % over the past 5 years at 14.45%.
- The lowest DepAmor % recorded by MYRIAD GENETICS INC in the same timeframe 8.36%
MYRIAD GENETICS INC's DepAmor % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
DepAmor % Benchmarks
Similar metrics to Revenues:
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation, Amortization & Accretion - [Cash Flow Statement] A component of operating cash flow [NCFO] representing the aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a non-cash item, the net amount is added back to net income when calculating cash provided by operations.
Definition of Depreciation and Amortization Margin
[Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].DepAmor / Revenues
(=) DepAmor % DepAmor % for MYRIAD GENETICS INC is calculated as follows: DepAmor [ $ 74.8M ] / Revenues [ $ 597.5M ]
(=) DepAmor % [ 12.52% ] MYGN - Depreciation and Amortization Margin, Last 5 years
8.36%
Minimum
Jun 30, 2025
14.45%
Maximum
Mar 31, 2021
10.34%
Average
9.77%
Median
DepAmor % Benchmark AnalysisMarket
The chart above depicts the distribution of DepAmor % for companies in the Total Stock Market. The average DepAmor % of the companies is 5.85% with a standard deviation of 5.13%.
The following table provides additional summary stats:
DepAmor % in the Market:
| filtered constituents | 3.32K |
|---|---|
| min | -6.41% |
| max | 22.52% |
| average | 5.85% |
| median | 4.2% |
| std | 5.13% |